induced Pluripotent Stem Cells– tag –
-
Japan Approves Stem Cell Therapy for Parkinson’s Disease: Kyoto University Research Paves Way for Clinical Application
Facebook (repost of news, citing Kyoto University research) Japan Overview According to news reposts citing Kyoto University research, Japan has approved a stem cell therapy for Parkinson's disease treatment. This approval marks a major ... -
Japan Leads Global Stem Cell Research, Excels in Treatment Costs, Methods, and Safety
PlacidWay Japan Overview A PlacidWay infographic report highlights Japan as a global leader in regenerative medicine research, emphasizing its highly structured regulatory environment for stem cell therapy. Japan is particularly well-sui... -
Patient-Specific iPSCs in Organ-on-a-Chip Systems: Pioneering Personalized Medicine and Drug Testing
PMC International Overview Organ-on-a-chip (OoC) systems innovatively mimic human organ structures and functions at a micro-scale. Induced pluripotent stem cells (iPSCs) serve as an ideal platform for constructing patient-specific OoC mo... -
Kyoto University iPSC Research Foundation Opens ‘Yanai my iPS Manufacturing Facility’ to Massively Enhance Clinical-Grade Autologous iPSC Production in Japan
BigGo Finance Japan Overview In 2025, with a substantial investment from Uniqlo founder Tadashi Yanai, the Kyoto University iPSC Research Foundation officially opened the 'Yanai my iPS Manufacturing Facility.' This marks Japan's first cl... -
Japan Establishes Rigorous Regulatory Framework for Stem Cell and Regenerative Medicine under ASRM
PlacidWay Japan Overview Japan has implemented a stringent regulatory framework for stem cell therapy and regenerative medicine, based on the Act on the Safety of Regenerative Medicine (ASRM). The Ministry of Health, Labour and Welfare (... -
Liv Hospital Advances iPSC Reprogramming, Sets Sights on Scalable Production for Regenerative Medicine
Liv Hospital Turkey Overview Liv Hospital's latest research details critical optimizations in induced pluripotent stem cell (iPSC) reprogramming, emphasizing advanced gene delivery systems and optimal vector selection for efficient and s... -
Breakthroughs in iPSC and 3D Organoids Drive Stem Cell Therapies Towards Clinical Reality and Scalable Manufacturing
Academic/Industry Publication Unknown Overview Stem cell therapies are transitioning rapidly from promise to clinical reality, driven by recent advances in iPSC generation and differentiation. Innovative transcription factor mixes now en...
1